Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms

Mee Soo Chang, Sun Ju Byeon, SunOch Yoon, Baek Hui Kim, Hye Seung Lee, Gyeong Hoon Kang, Woo Ho Kim, Kyu Joo Park

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: Leptin contributes to mucin production in colonic epithelium and regulates carcinogenesis via various signalling pathways. We evaluated the proteins involved in mucin-producing carcinogenesis and putative targets for molecular therapy in appendiceal mucinous neoplasms. Methods: Immunohistochemistry and fluorescence in situ hybridization were performed in 22 cases of appendiceal mucinous adenoma, 20 mucinous neoplasms of uncertain malignant potential and 14 mucinous adenocarcinomas. Results: Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05). STAT3 revealed immunopositivity in 82% of tumours, regardless of tumour category. MUC2 immunopositivity was associated with pseudomyxoma peritonei (p < 0.05). None of the tumours exhibited c-kitimmunoexpression, amplification of Her2 or EGFR, or translocation of ALK. The mTOR-immunopositive group of patients had a lower rate of disease-free survival compared with the mTOR-immunonegative group (p < 0.05). Conclusions: Leptin may collaborate with MUC2 and MUC5AC in mucin-producing carcinogenesis in an mTOR-, STAT3- and ERK-dependent manner. STAT3 may be activated early during tumorigenesis. MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.

Original languageEnglish
Pages (from-to)45-53
Number of pages9
JournalPathobiology
Volume79
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Appendiceal Neoplasms
Leptin
Mucinous Adenocarcinoma
Carcinogenesis
Mucins
Pseudomyxoma Peritonei
Neoplasms
Adenoma
Fluorescence In Situ Hybridization
Disease-Free Survival
Epithelium
Immunohistochemistry
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Chang, M. S., Byeon, S. J., Yoon, S., Kim, B. H., Lee, H. S., Kang, G. H., ... Park, K. J. (2012). Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms. Pathobiology, 79(1), 45-53. https://doi.org/10.1159/000332739
Chang, Mee Soo ; Byeon, Sun Ju ; Yoon, SunOch ; Kim, Baek Hui ; Lee, Hye Seung ; Kang, Gyeong Hoon ; Kim, Woo Ho ; Park, Kyu Joo. / Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms. In: Pathobiology. 2012 ; Vol. 79, No. 1. pp. 45-53.
@article{85cdec52b59546aeabbb363875b566ba,
title = "Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms",
abstract = "Objective: Leptin contributes to mucin production in colonic epithelium and regulates carcinogenesis via various signalling pathways. We evaluated the proteins involved in mucin-producing carcinogenesis and putative targets for molecular therapy in appendiceal mucinous neoplasms. Methods: Immunohistochemistry and fluorescence in situ hybridization were performed in 22 cases of appendiceal mucinous adenoma, 20 mucinous neoplasms of uncertain malignant potential and 14 mucinous adenocarcinomas. Results: Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05). STAT3 revealed immunopositivity in 82{\%} of tumours, regardless of tumour category. MUC2 immunopositivity was associated with pseudomyxoma peritonei (p < 0.05). None of the tumours exhibited c-kitimmunoexpression, amplification of Her2 or EGFR, or translocation of ALK. The mTOR-immunopositive group of patients had a lower rate of disease-free survival compared with the mTOR-immunonegative group (p < 0.05). Conclusions: Leptin may collaborate with MUC2 and MUC5AC in mucin-producing carcinogenesis in an mTOR-, STAT3- and ERK-dependent manner. STAT3 may be activated early during tumorigenesis. MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.",
author = "Chang, {Mee Soo} and Byeon, {Sun Ju} and SunOch Yoon and Kim, {Baek Hui} and Lee, {Hye Seung} and Kang, {Gyeong Hoon} and Kim, {Woo Ho} and Park, {Kyu Joo}",
year = "2012",
month = "1",
day = "1",
doi = "10.1159/000332739",
language = "English",
volume = "79",
pages = "45--53",
journal = "Pathobiology",
issn = "1015-2008",
publisher = "S. Karger AG",
number = "1",

}

Chang, MS, Byeon, SJ, Yoon, S, Kim, BH, Lee, HS, Kang, GH, Kim, WH & Park, KJ 2012, 'Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms', Pathobiology, vol. 79, no. 1, pp. 45-53. https://doi.org/10.1159/000332739

Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms. / Chang, Mee Soo; Byeon, Sun Ju; Yoon, SunOch; Kim, Baek Hui; Lee, Hye Seung; Kang, Gyeong Hoon; Kim, Woo Ho; Park, Kyu Joo.

In: Pathobiology, Vol. 79, No. 1, 01.01.2012, p. 45-53.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms

AU - Chang, Mee Soo

AU - Byeon, Sun Ju

AU - Yoon, SunOch

AU - Kim, Baek Hui

AU - Lee, Hye Seung

AU - Kang, Gyeong Hoon

AU - Kim, Woo Ho

AU - Park, Kyu Joo

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objective: Leptin contributes to mucin production in colonic epithelium and regulates carcinogenesis via various signalling pathways. We evaluated the proteins involved in mucin-producing carcinogenesis and putative targets for molecular therapy in appendiceal mucinous neoplasms. Methods: Immunohistochemistry and fluorescence in situ hybridization were performed in 22 cases of appendiceal mucinous adenoma, 20 mucinous neoplasms of uncertain malignant potential and 14 mucinous adenocarcinomas. Results: Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05). STAT3 revealed immunopositivity in 82% of tumours, regardless of tumour category. MUC2 immunopositivity was associated with pseudomyxoma peritonei (p < 0.05). None of the tumours exhibited c-kitimmunoexpression, amplification of Her2 or EGFR, or translocation of ALK. The mTOR-immunopositive group of patients had a lower rate of disease-free survival compared with the mTOR-immunonegative group (p < 0.05). Conclusions: Leptin may collaborate with MUC2 and MUC5AC in mucin-producing carcinogenesis in an mTOR-, STAT3- and ERK-dependent manner. STAT3 may be activated early during tumorigenesis. MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.

AB - Objective: Leptin contributes to mucin production in colonic epithelium and regulates carcinogenesis via various signalling pathways. We evaluated the proteins involved in mucin-producing carcinogenesis and putative targets for molecular therapy in appendiceal mucinous neoplasms. Methods: Immunohistochemistry and fluorescence in situ hybridization were performed in 22 cases of appendiceal mucinous adenoma, 20 mucinous neoplasms of uncertain malignant potential and 14 mucinous adenocarcinomas. Results: Leptin, MUC2, MUC5AC, mTOR and ERK were more frequently immunopositive in mucinous adenocarcinomas compared with mucinous adenomas or mucinous neoplasms of uncertain malignant potential (p < 0.05). STAT3 revealed immunopositivity in 82% of tumours, regardless of tumour category. MUC2 immunopositivity was associated with pseudomyxoma peritonei (p < 0.05). None of the tumours exhibited c-kitimmunoexpression, amplification of Her2 or EGFR, or translocation of ALK. The mTOR-immunopositive group of patients had a lower rate of disease-free survival compared with the mTOR-immunonegative group (p < 0.05). Conclusions: Leptin may collaborate with MUC2 and MUC5AC in mucin-producing carcinogenesis in an mTOR-, STAT3- and ERK-dependent manner. STAT3 may be activated early during tumorigenesis. MUC2 and mTOR (but not c-kit, Her2, EGFR and ALK) may represent targets for molecular therapy in pseudomyxoma peritonei and appendiceal mucinous adenocarcinoma, respectively.

UR - http://www.scopus.com/inward/record.url?scp=84862909317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862909317&partnerID=8YFLogxK

U2 - 10.1159/000332739

DO - 10.1159/000332739

M3 - Article

VL - 79

SP - 45

EP - 53

JO - Pathobiology

JF - Pathobiology

SN - 1015-2008

IS - 1

ER -

Chang MS, Byeon SJ, Yoon S, Kim BH, Lee HS, Kang GH et al. Leptin, MUC2 and mTOR in appendiceal mucinous neoplasms. Pathobiology. 2012 Jan 1;79(1):45-53. https://doi.org/10.1159/000332739